MetaCap

CDT Environmental Technology Investment (CDTG) vs Clinuvel Pharmaceuticals (CUVL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Clinuvel Pharmaceuticals is the larger company by market cap ($280.7 million vs $3.8 million), about 74.3 times the size. Clinuvel Pharmaceuticals pays a dividend yielding 0.90%, while CDT Environmental Technology Investment does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CDTG versus CUVL key metrics
MetricCDTGCUVL
Share price$1.25$5.56
Market cap$3.78M$280.71M
1-day change+16.01%-4.14%
YTD return—-31.60%
1-year return—-29.70%
5-year return—-80.95%
P/E ratio (TTM)—12.36
EPS (TTM)$-21.00$0.45
Dividend yield0.00%0.90%
Annual dividend$0.00$0.05
52-week high$18.13$8.92
52-week low$0.73$5.53
Distance from 52-week high-93.10%-37.67%
Average volume4.35M12.84K
Shares outstanding3.02M50.49M
SectorIndustrialsMiscellaneous
IndustryMiscellaneousMiscellaneous

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Clinuvel Pharmaceuticals is about 74.3 times larger than CDT Environmental Technology Investment by market value ($280.71M vs $3.78M).
  • The two companies sit in different sectors: CDT Environmental Technology Investment in Industrials and Clinuvel Pharmaceuticals in Miscellaneous.

About Clinuvel Pharmaceuticals

CUVL stock →

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).

Miscellaneous · Miscellaneous

CDTG vs CUVL FAQ

Which is bigger, CDT Environmental Technology Investment or Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals (CUVL) is larger, with a market capitalization of $280.71M compared with $3.78M for CDT Environmental Technology Investment (CDTG).

Which pays a higher dividend, CDT Environmental Technology Investment or Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals pays a dividend yielding 0.90%, while CDT Environmental Technology Investment does not currently pay a regular dividend.

Are CDT Environmental Technology Investment and Clinuvel Pharmaceuticals in the same industry?

Yes. Both are classified in the Miscellaneous industry within the Industrials sector.

More comparisons